Healthcare -
Medical - Devices - NYSE - US
$ 185.19
-0.216 %
$ 5.49 B
Market Cap
106.43
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Inspire Medical Systems, Inc.
| Revenue | 803 M |
| Cost Of Revenue | 123 M |
| Gross Profit | 680 M |
| Operating Expenses | 644 M |
| Operating Income | 36.1 M |
| Other Expenses | -17.4 M |
| Net Income | 53.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 802.8 | 624.8 | 407.9 | 233.4 | 115.4 | 82.0 | 50.6 | 28.6 | 16.4 | 8.0 |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 123.0 | 96.6 | 66.1 | 33.3 | 17.6 | 13.6 | 10.1 | 6.0 | 3.9 | 2.8 |
| Gross Profit | 679.8 | 528.2 | 341.7 | 200.1 | 97.8 | 68.4 | 40.5 | 22.5 | 12.5 | 5.2 |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 643.7 | 568.5 | 389.3 | 240.0 | 154.0 | 103.3 | 60.9 | 38.6 | 29.8 | 25.0 |
| Selling, General and Administrative Expenses | 529.6 | 452.0 | 320.7 | 202.6 | 127.9 | 90.5 | 53.5 | 32.4 | 22.7 | 17.9 |
| Research and Development Expenses | 114.1 | 116.5 | 68.6 | 37.4 | 26.1 | 12.8 | 7.4 | 6.2 | 7.1 | 7.1 |
| Operating Income | 36.1 | (40.3) | (47.6) | (39.9) | (56.2) | (34.9) | (20.4) | (16.0) | (17.3) | (19.8) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | 22 K | 0 | 1.7 | 2.1 | 2.1 | 2.1 | 3.3 | 1.8 | 1.3 | 1.6 |
| Total Other Income | 22.4 | 20.4 | 3.3 | (2.1) | (0.9) | 1.7 | (1.4) | (1.5) | (1.3) | (1.5) |
| Pre-Tax Income | 58.5 | (19.9) | (44.3) | (42.0) | (57.1) | (33.2) | (21.8) | (17.5) | (18.5) | (21.3) |
| NET INCOME | ||||||||||
| Tax Provision | 4.9 | 1.2 | 0.6 | 72 K | 0.1 | 40 K | 1.9 | 1.8 | 1.3 | 1.5 |
| Net Income | 53.5 | (21.2) | (44.9) | (42.0) | (57.2) | (33.2) | (21.8) | (17.5) | (18.5) | (21.3) |
| EPS | 1.8 | 0.72 | 1.6 | 1.54 | 2.19 | 1.4 | 1.5 | 1.3 | 1.49 | 1.71 |